Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges

scientific article published in November 2006

Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1586/17434440.3.6.683
P698PubMed publication ID17280531
P5875ResearchGate publication ID6523281

P2093author name stringThomas J Webster
Peishan Liu-Snyder
P2860cites workCovalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.Q48608387
Multi-pulse drug delivery from a resorbable polymeric microchip device.Q51797551
Astrocytes induce blood–brain barrier properties in endothelial cellsQ57318253
A controlled-release microchipQ59058736
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databasesQ28140411
Biodegradation and biocompatibility of PLA and PLGA microspheresQ33933142
Astrocyte-endothelial interactions and blood-brain barrier permeabilityQ33960608
The therapeutic potential of iron chelatorsQ34119571
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trialQ34283745
The effect of thermotherapy using magnetic nanoparticles on rat malignant gliomaQ34471154
Implantable, polymeric systems for modulated drug deliveryQ34977237
Shaping biodegradable polymers as nanostructures: Fabrication and applicationsQ35198829
Targeted therapy for brain tumoursQ35790376
Current treatment of mild cognitive impairment and Alzheimer's diseaseQ36575001
Transport of opioid peptides into the central nervous system.Q44350552
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseasesQ45231701
Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to ratsQ45803643
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrierQ46451836
Toxicity and tissue distribution of magnetic nanoparticles in mice.Q46764075
Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticlesQ47352466
Global non-viral gene transfer to the primate brain following intravenous administrationQ48393623
Copper, iron and zinc in Alzheimer's disease senile plaquesQ48429285
Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalanceQ48443119
Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structuresQ48587174
P433issue6
P921main subjectnanotechnologyQ11468
drug deliveryQ1392806
P304page(s)683-687
P577publication date2006-11-01
P1433published inExpert Review of Medical DevicesQ15762322
P1476titleDesigning drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges
P478volume3

Reverse relations

Q47251179Free Bioverit II implants coated with a nanoporous silica layer in a mouse ear model-- a histological studycites workP2860

Search more.